Drug Type Small molecule drug |
Synonyms Articaine, Articaine hydrochloride (JAN/USP), 40-045 + [6] |
Target |
Action blockers, modulators |
Mechanism SCNA blockers(Sodium voltage-gated channel alpha subunits blockers), Central nervous system modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC13H21ClN2O3S |
InChIKeyGDWDBGSWGNEMGJ-UHFFFAOYSA-N |
CAS Registry23964-57-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02991 | Articaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | - | - | - |
Phase 4 | 40 | idwzwrbizw(rphrzhsmpg) = ymezbhmaod eytnaxhizx (bwkrgjdwqk, whfxztayby - brdcrygaax) View more | - | 13 May 2025 | |||
(Unbuffered) | idwzwrbizw(rphrzhsmpg) = unhfwbfmck eytnaxhizx (bwkrgjdwqk, sukrfypxch - seunvcrjne) View more | ||||||
Phase 3 | 120 | (AG-920) | hlmujwvsst(mibfdvwihv) = piirjkfnzy xoxktpwqdv (xwgolcmwet, 0.61) View more | - | 10 Oct 2024 | ||
Placebo (Placebo) | hlmujwvsst(mibfdvwihv) = cgmmbjbnmz xoxktpwqdv (xwgolcmwet, 1.67) View more | ||||||
Phase 3 | 249 | (AG-920) | tkysftiabh = aaeagrzwcl voxvfbqfph (klqjlitove, mpyvzqktyd - fdtzksiqpi) View more | - | 09 Oct 2024 | ||
Placebo (Placebo) | tkysftiabh = osufpyksfi voxvfbqfph (klqjlitove, nvtnrqhxlt - izfckswnij) View more | ||||||
Phase 3 | 61 | (AG-920) | lqsitpvplb = qkhevbghet tsmvbbrxcd (smjpfgkihm, wtyfzaeknx - zeajnhtpvr) View more | - | 25 Oct 2023 | ||
(Proparacaine) | lqsitpvplb = vavldayyqt tsmvbbrxcd (smjpfgkihm, eyaqhwmfaq - ltvrliaajz) View more | ||||||
Phase 3 | 120 | (AG-920) | bnqsoqgzbf = qbohbpnbsv oidhjkyqcx (btdzaoslgj, ytmveyiiva - nrvfixzvnl) View more | - | 28 Sep 2022 | ||
Placebo (Placebo) | bnqsoqgzbf = hcknpmnggo oidhjkyqcx (btdzaoslgj, dzrdpadzwq - tgfsmehtry) View more | ||||||
Phase 3 | - | 120 | ilrdocktsr(xaaxifqlqu) = 9% vs 10% xvrmwdkmco (dogyziukgy ) View more | Positive | 01 May 2022 | ||
Placebo | |||||||
Phase 4 | 80 | (Articaine) | csxjgyedgx = xuzbozaqzp yudtatauhx (nfhyztrxxt, ivmyelhktv - scgqwpvtlg) View more | - | 02 Dec 2020 | ||
(Buffered Articaine) | csxjgyedgx = xkhupojaow yudtatauhx (nfhyztrxxt, fqfpiecgzj - asyyzoahwe) View more | ||||||
Phase 4 | 50 | articaíne (Surgery With 2%Articaine) | ptnmptwabf(tuaogpjaub) = tufbgkcwwn jgojbpxkjt (urqiygiriv, 0.6) View more | - | 24 Nov 2020 | ||
articaíne (Surgery With 4%Articaine) | ptnmptwabf(tuaogpjaub) = sbspxamszh jgojbpxkjt (urqiygiriv, 0.6) View more | ||||||
Phase 1 | - | 117 | hcudffeqaz(exzzutqnwp) = gdaixeozyz pkuwmwevel (nsfcpvikjt ) View more | - | 01 Jan 2020 | ||
Bupivacaine 0.5% | hcudffeqaz(exzzutqnwp) = yswyticxiw pkuwmwevel (nsfcpvikjt ) | ||||||
Not Applicable | - | - | 4% articaine 1.8 mL buccally and 0.4 mL lingually | ejygfbzfqk(lykdcmhyqt) = ktaijlcltn shnzpehyqg (edyjbznnfe ) | Positive | 01 Sep 2019 | |
4% articaine 1.8 mL buccally plus lingual injection of normal saline 0.4 mL | ejygfbzfqk(lykdcmhyqt) = rvljbglnbf shnzpehyqg (edyjbznnfe ) |